Sign Up Today and Learn More About Vilya Stock
Invest in or calculate the value of your shares in Vilya or other pre-IPO companies through EquityZen's platform.

Vilya Stock (VILY)
Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.
About Vilya Stock
Founded
2022
Headquarters
Seattle, WA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Vilya Press Mentions
Stay in the know about the latest news on Vilya
Vilya Announces Exclusive License Agreement of RFdiffusion-based Generative Model from the University of Washington for the Design of Macrocyclic Peptides
globenewswire • Nov 21, 2024
Vilya Expands Series A Financing to $71M
finsmes • Jun 26, 2024
Vilya Expands Series A Financing to $71 Million to Advance Computational Drug Design and Develop a New Class of ...
finance • Jun 26, 2024
With $71M in funding, Seattle biotech Vilya looks to get 'close to the clinic'
bizjournals • Jun 10, 2024
Vilya raises $21M in Series A extension; Shionogi to build research center in San Diego
sdbn • Jun 05, 2024

Join now and verify your accreditation status to gain access to:
- Vilya Current Valuation
- Vilya Stock Price
- Vilya Management
- Available deals in Vilya and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Vilya Cap Table and Funding History by Share Class and Liquidity Preferences
- Vilya Revenue and Financials
- Vilya Highlights
- Vilya Business Model
- Vilya Risk Factors
- Vilya Research Report from SACRA Research
Trading Vilya Stock
How to invest in Vilya stock?
Accredited investors can buy pre-IPO stock in companies like Vilya through EquityZen funds. These investments are made available by existing Vilya shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Vilya stock?
Shareholders can sell their Vilya stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."